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Abstract
Background: Noroviruses (NoV) have become one of the most commonly reported causative
agents of large outbreaks of non-bacterial acute gastroenteritis worldwide as well as sporadic
gastroenteritis in the community. Currently, reverse transcriptase polymerase chain reaction (RT-
PCR) assays have been implemented in NoV diagnosis, but improvements that simplify and
standardize sample preparation, amplification, and detection will be further needed. The
combination of automated sample preparation and real-time PCR offers such refinements.
Methods: We have designed a new real-time RT-PCR assay on the LightCycler (LC) with SYBR
Green detection and melting curve analysis (Tm) to detect NoV RNA in patient stool samples. The
performance of the real-time PCR assay was compared with that obtained in parallel with a
commercially available enzyme immunoassay (ELISA) for antigen detection by testing a panel of 52
stool samples. Additionally, in a collaborative study with the Baden-Wuerttemberg State Health
office, Stuttgart (Germany) the real-time PCR results were blindly assessed using a previously well-
established nested PCR (nPCR) as the reference method, since PCR-based techniques are now
considered as the "gold standard" for NoV detection in stool specimens.
Results: Analysis of 52 clinical stool samples by real-time PCR yielded results that were consistent
with reference nPCR results, while marked differences between the two PCR-based methods and
antigen ELISA were observed. Our results indicate that PCR-based procedures are more sensitive
and specific than antigen ELISA for detecting NoV in stool specimens.
Conclusions: The combination of automated sample preparation and real-time PCR provided
reliable diagnostic results in less time than conventional RT-PCR assays. These benefits make it a
valuable tool for routine laboratory practice especially in terms of rapid and appropriate outbreak-
control measures in health-care facilities and other settings.
Background
NoV, members of the family Caliciviridae, are single-
stranded RNA, nonenveloped viruses. Based on antigenic
and genetic distinctions NoV (formerly called Norwalk-
like viruses) can be divided in 5 different genogroups [1].
Since the first identification of this pathogen in 1972 [2],
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NoV have become one of the most commonly reported
causative agents of large outbreaks of non-bacterial gastro-
enteritis worldwide as well as sporadic gastroenteritis in
the community [3-6]. NoV usually cause acute self-limited
infections in humans of all ages. However, NoV infection
can be severe in frail elderly persons, young children, and
immunocompromised persons and medical attention
may be required to prevent dehydration and nosocomial
spread. After an incubation period of 1 to 3 days, the clin-
ical manifestations are characterized by diarrhoea that
lasts 12 to 60 hours and is frequently accompanied by a
variety of other symptoms such as nausea, vomiting, and
abdominal cramps. Headache and low-grade fever are
also commonly reported with NoV illness (reviewed in
[7]). Viral spread from person-to-person via the faecal-
oral route or through vomiting is the major mode [8], but
also the importance of food and water in disease transmis-
sion is well-recognized [9-11].
Initially, direct and immune electron microscopy (EM)
were used to detect the presence of NoV in fecal speci-
mens, however EM diagnosis has a low sensitivity and is
dependent upon collection of samples 2–3 days after the
onset of illness. Moreover, EM is not routinely imple-
mented in the laboratory because of technical limitations
and dependency on trained medical staff for its operation.
With the breakthrough in cloning and sequencing of NoV
genome, antigen detection assays based on baculovirus-
expressed NoV capsid antigens have been developed
(reviewed in [12]). These assays are type-specific, however
they are not broadly reactive. Subsequently, RT-PCR
assays have become the method of choice both due to
their unsurpassed sensitivity and the ability to detect
genetically diverse NoV strains [13-20]. Today, there is
keen interest for standardization and automation for
molecular tests.
The combination of automated sample preparation using
the MagNA Pure extraction robot and the LightCycler PCR
system (both Roche Applied Science, Mannheim, Ger-
many) now provides such a standardized application for-
mat. Unlike the classic RT-PCR techniques, the closed
format of real-time PCR avoids carryover contaminations
with amplified products. As a result of reduced cycle times
and lack of post-amplification processing steps, the turn-
around time of the assay is considerably shorter and test
results can be generated in a timely manner.
Here, we describe the application of a SYBR Green based
real-time PCR assay to directly detect the presence of NoV
RNA in stool specimens using the LC instrument. The
results of the new assay were evaluated against antigen
ELISA and nPCR results. The objectives of this study were
to determine the test characteristics such as reliability and
reproducibility, as well as to assess the clinical value of the
new assay. A particular goal was to combine a real-time
PCR-based approach with an automated sample prepara-
tion system, which is especially beneficial for clinical lab-
oratories handling large numbers of specimens.
Methods
Samples
A total of 52 routine diagnostic samples from different
patients were used in this study. The samples were col-
lected from January 2003 through April 2003. Although
we have collected the samples within a short period of
time, the samples originate from various geographical
areas in Germany. Of the 52 samples, 38 were obtained
from patients implicated in several outbreaks of supposed
gastroenteritis in different settings, including nursing and
residential homes, and hospitals. Unfortunately, only
data of age and gender are available (13.1% were less than
10 years of age, 39.5% between 10 and 60 years, and
47.4% more than 60 years old). The remaining 14 sam-
ples were cases of single sporadic gastroenteritis obtained
from children <5 years of age, which have been already
tested for rotavirus and adenovirus by antigen ELISA.
These patients presented clinical symptoms of acute diar-
rhoea (loose or watery stools, diarrhoea with vomiting,
nausea, and associated symptoms including fever or signs
of dehydration).
Fecal specimens were collected each in sterile containers
and immediately processed upon receipt for real-time
PCR and antigen ELISA and stored at -20°C until further
processing by nPCR.
Sample processing
For real-time PCR testing, a 10% (wt/vol) stool suspen-
sion was prepared in 500 µl PCR-grade water, and centri-
fuged at 16.000 × g for 5 min at room temperature. 200 µl
of the clarified supernatant was used for extraction of RNA
on the MagNA Pure instrument.
Automated nucleic acid isolation
Viral RNA preparation was performed on the automated
MagNA Pure instrument by using the MagNA Pure total
nucleic acid isolation kit (Roche Applied Science, Man-
nheim, Germany). The MagNA Pure is a benchtop instru-
ment that can extract nucleic acids from 32 samples in
parallel. The instrument software guides the user through
the set up procedure and automatically calculates the
amount of reagents needed for processing. All remaining
pipetting steps of the procedure were automatically per-
formed with aerosol-preventive, disposable reaction tips.
After incubation with a chaotropic lysis buffer and protei-
nase K, nucleic acids were released and bound to magnetic
glass particles. Unbound molecules are removed byBMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/15
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several washing steps and RNA eluted in 60 µl elution
buffer. Purified RNA was stored at -20°C.
Primer
Primer sets from previously published assays which
amplify a conserved region within the RNA-dependent
RNA polymerase gene were used. Sequences were com-
pared against those listed in GenBank by using the basic
local alignment search tool (BLAST) to ensure a high level
of specificity against NoV. Oligonucleotide primers used
in this study are listed in Table 1.
Real-time PCR
Real-time PCR was done using the LightCycler system
with SYBR Green detection and Tm analysis. QuantiTect™
SYBR® Green RT-PCR kit was purchased from Qiagen,
(Qiagen, Hilden, Germany). Amplification is performed
in a total volume of 20 µl containing 10 µl of kit-supplied
QuantiTect™ SYBR® Green RT-PCR Master mix (including
HotStar Taq DNA polymerase, reaction buffer, dNTP mix,
and SYBR dye), 0.5 µM of each primer, 1 µl RNase-free
water, 0.2 µl kit-supplied QuantiTect RT mix (reverse tran-
scriptase), and 6.8 µl of probe. Prior to cycling, the glass
capillaries are sealed, placed into the LC sample carousel,
and centrifuged at 700 × g for 5 s in the LC carousel cen-
trifuge (Roche). Amplification conditions consisted of
four consecutive phases: (i) a reverse transcription step
(50°C for 20 min), (ii) an initial denaturation step in
order to activate the HotStarTaq DNA Polymerase (95°C
for 15 min), (iii) a touch-down profile for 10 cycles (94°C
for 5 sec, 65°C for 15 sec and 72°C for 25 sec) with a 1°C
step size temperature ramp per cycle from 65°C to 55°,
(iv) an amplification step for 26 cycles (94°C for 15 sec,
55°C for 15 sec, and 72°C for 25 sec). To identify PCR
products generated in the presence of SYBR Green, a Tm
analysis is performed by increasing the temperature from
60°C to 90°C at a linear transition rate of 0.1°C/sec. Flu-
orescence of the samples is monitored continuously while
the temperature is increased. SYBR Green is released upon
denaturation, which results in a decreasing fluorescence
of the signal. The LC software calculates the Tm, i.e. the
rate of change in fluorescence (-dF/dT) is displayed as a
function of temperature. All samples were analyzed once.
Recommended optimisation by titration of appropriate
primer concentrations was performed.
Controls
To monitor crossover contaminations 200 µl of PCR-
grade water was included in the RNA extraction procedure
and used as a negative control. To ensure quality and
reproducibility of data, both a low-run control (i.e. puri-
fied NoV RNA) and a negative control were always
applied in each run. In order to prevent PCR carryover
contamination extraction of nucleic acids and amplifica-
tion were performed in different rooms. Barrier-filtered
pipette were used in all manipulations with the samples.
Interpretation
A sample was only considered positive if both the sample
quantification curve became exponential, and the PCR
product was correctly differentiated by the Tm analysis
step.
NoV detection by nested RT-PCR
NoV RNA was extracted from coded patients's specimens
using a method based on the lysing and nuclease-inacti-
vating properties of guanidinium thiocyanate with the
nucleic acid-binding properties of silica particles [21]. A
20% (wt/vol) stool suspension was prepared in 1 ml PCR-
grade water, vortexed, and centrifuged at 16.000 × g for 3
min. Reaction vessels were prepared with 900 µl lysis
buffer (5.25 M GuSCN, 50 mM Tris HCl, pH 6.4, 20 mM
Table 1: Summary of NoV primers used
Real-time PCR (polymerase gene)
Primer Location Oligonucleotide sequence (5' - 3') Reference
NV p110a 4865 - 4883 ACDATYTCATCATCACCATA 18
NV p36a 4487 - 4505 ATAAAAGTTGGCATGAACA 15
NV NIb 4495 - 4515 GAATTCCATCGCCCACTGGCT 17
Nested PCR (polymerase gene)
Primer Location Oligonucleotide sequence (5' - 3') Reference
Primer 32b 4226 - 4245 ATGAATATGAATGAAGATGG 23
Primer 36a 4980 - 4961 ATTGGTCCTTCTGTTTTGTC 23
Primer 35a 4890 - 4871 GTTGACACAATCTCATCATC 23
Primer 33b 4280 - 4299 TACCACTATGATGCAGATTA 23
Annealing site refer to aGenBank accession no. M87661 and bGenBank no X86557BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/15
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EDTA, 1.3% wt/vol Triton X-100) and 40 µl of silica
matrix to a 2 ml Eppendorf reaction tube. 300 µl of the
clarified supernatant was added to the reaction vessels,
and immediately vortexed. After 10 min at room temper-
ature, the vessel was vortexed again and centrifuged at
16.000 × g for 15 s. The supernatant was disposed of by
suction. The silica pellet was subsequently washed twice
with 1 ml washing buffer (5.25 M GuSCN, 50 mM Tris
HCl, pH 6.4), twice with 1 ml ethanol 70% (vol/vol), and
once with 1 ml acetone. After centrifugation (3 min at
approximately 16.000 × g), the supernatant was disposed
of by suction. The vessels were dried at 56°C with open
lids in a heat block for 10 min. For elution, 75 µl nuclease
free water and 1 µl rRNasin (Promega, Mannheim, Ger-
many) were added, and the closed vessel was vortexed
briefly, and incubated for 10 min at 56°C. The vessel was
vortexed again and centrifuged for 3 min at 16.000 × g.
For reverse transcription (RT) 5 µl of the DNA and RNA
containing supernatant was used. RT was carried out with
the AMV-RT (Roche Applied Science, Mannheim, Ger-
many) and the antisense primer 36. RT was performed for
one cycle (25°C, 10 min; 42°C, 60 min; 98°C, 5 min).
Part of the cDNA was amplified by nested PCR using
primer 32 and primer 36 for the first round, and primer
33 and primer 35 for the second round. Amplifications
were performed for 35 cycles (94°C, 30 s; 42°C, 30 s;
72°C, 45 s). The cycles were proceeded by a 1 min dena-
turation and followed by a 3 min extension at 72°C. PCR
products were visualized on agarose gels after electro-
phoresis coupled with ethidium bromide staining and
viewed on a UV transilluminator. Nested PCR was per-
formed in a second laboratory without knowledge of LC-
PCR test results. The sensitivity of the nPCR using serial
dilutions of spiked clinical specimens was comparable to
real-time PCR analysis. Primer sequence and nested RT-
PCR set up have been previously described [22].
NoV detection by antigen ELISA
The RIDASCREEN® Norwalk-like Virus kit was purchased
from R-Biopharm (R-Biopharm, Darmstadt, Germany)
and used for the detection of Norwalk-like viruses (NLVs)
of the genogroup I and II in stool specimens. This enzyme
immunoassay is based on monoclonal antibodies bound
on the surface of the microwell strips to capture the anti-
gen in stool specimens. All reagents were kit-supplied. For
sample preparation, stool samples were diluted 1:6 (v/v)
in the diluent buffer, mixed thoroughly, allowed 5–10
min to settle, and further processed according to the pro-
tocol recommended by the manufacturer. Briefly, 100 µl
supernatant of the prepared stool suspension are trans-
ferred into separate wells and incubated at room temper-
ature for 60 min. After complete removing of the liquid,
the wells are washed 5 times with 300 µl wash buffer. Two
drops of enzyme conjugate are added to each well, incu-
bated at room temperature for 30 min. After 5 times wash-
ing (see above), the bound conjugate was determined by
the addition of a chromogen and enzyme substrate. The
absorbance is measured at 450 nm. The kit cut-off used is
determined by addition of 0.15 absorbance units to the
measured absorption (450 nm) of the negative control.
Statistical analysis
Comparisons involving Ct values of PCR-positive ELISA-
positive and PCR-positive but ELISA-negative samples
were analysed by the Mann-Whitney U test using statisti-
cal software SPSS, version 11.5.1 (SPSS inc., Chicago,
USA). For comparison of proportion the chi square test
was used.
Results
Optimization strategies
Real-time PCR affords continuous monitoring of the PCR
reaction cycle by cycle by using fluorescence. The detec-
tion in our assay is based on the binding of the fluorescent
dye SYBR Green, which binds all double stranded DNA
molecules. Since this process is sequence independent,
the characteristic Tm of the target is determined by per-
forming a melting curve analysis on the PCR products. To
reduce the formation of primer-dimers and non-specific
products, which compete with formation of specific PCR
products, leading to reduced amplification efficiency, we
include a touch-down step in the thermal cycling pro-
gram. By using restricted annealing temperature, forma-
tion of unexpected double-stranded DNA products and
primer-dimers were not observed (Fig. 1). In addition,
both purity and concentration of primers are essential for
optimal working conditions.
Detection range, sensitivity, specificity, reproducibility
To validate the real-time assay prior to application, we
determined the detection range using tenfold serial dilu-
tions of a patient's stool sample. The assay was able to
detect NoV RNA within a range of up to 5 logs. The result-
ing curve with a slope of -3.251, and a coefficient of cor-
relation r = -0.99 indicates a high efficiency of RT-PCR and
a strong linear relationship (results not shown). Tm analy-
sis of the PCR product revealed a distinct temperature at
which the double stranded amplicon is denatured (mean
Tm 78.9°C; range 78.2 to 81.2). No increase in fluores-
cence signal from primer-dimers or other non-specific
amplification products (distinguished from the specific
product through their lower Tm) was monitored (Fig. 1).
To assess specificity, we tested the assay with RNA or DNA
(high run controls as templates) from several viral patho-
gens usually associated with gastroenteritis diseases. No
cross-amplification was observed when a panel of enteric
viruses, including hepatitis A, hepatitis E, enterovirus,
rotavirus and adenovirus, was tested as described above
for NoV (results not shown). Reproducibility of the assay
was evaluated by measuring the threshold cycle (Ct), i.e.BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/15
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the cycle with the first detectable increase in fluorescence,
of a low run control on three consecutive days six times.
To determine the intra-assay precision, three stool speci-
men were simultaneously tested three times. The assay
showed a between-run coefficient of variation (CV) of
<3%, while the within-run coefficient was <2%, indicat-
ing that the assay was efficiently reproducible.
Comparison of results obtained by real-time PCR, antigen 
ELISA, and nPCR
Results of real-time PCR were compared with those of
antigen ELISA and reference nPCR. We found a 100% cor-
relation between the results of real-time PCR and those
obtained by nPCR. By antigen ELISA 18 of 52 (34.6%)
samples were positive for NoV, whereas both real-time
PCR and nPCR detected 26 (50%), respectively. Of the
antigen ELISA-positive samples, only 50% (9/18) were
confirmed by the two PCR-based methods. In contrast,
real-time PCR and nPCR detected 17 samples that were
not identified by antigen ELISA. An identical result in all
three tests was obtained in 50% (26/52) of the samples.
Seventeen specimens were negative by all tests. The mean
Ct value for real-time PCR was 28.9 [95% confidence
interval (CI), 27.3 to 30.5; range 18.5 to 34] and the mean
Tm was 78.9°C (95% CI 78.7 to 79.1; range 78.2 to 81.2).
All our negative controls showed no fluorescence signal.
The mean optical density (OD) value for antigen ELISA
was 1.0 (95% CI 0.5 to 1.5; range 0.2 to 3.6). Table 2
shows the combined results of antigen ELISA, real-time
PCR, and nPCR for the total of 52 specimens.
Tm analysis of real-time PCR with SYBR Green as fluorescent dye Figure 1
Tm analysis of real-time PCR with SYBR Green as fluorescent dye. Tm analysis allows the differentiation of specific PCR product 
(amplicon) from non-specific amplification products, such as primer-dimers. Samples: 1 to 7, patient samples (stool); 8, negative 
control (water); 9, positive control (NoV positive stool). Amplified products from NoV template RNA can be reliably distin-
guished from non-specific products by different melting points. The melting temperature for the positive samples was 79.0 +/- 
0.5°C. Non-specific products melt at lower temperatures.
Table 2: Pattern of NoV test results for 52 stool specimens
Results of:
Elisa Real-time PCR nPCR No. of specimens (N = 52)
++ + 9
-+ + 1 7
+- - 9
-- - 1 7BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/15
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Relative sensitivity
The choice of a reference test is crucial for evaluation of
any new assay. In order to ensure specificity of the new
real-time PCR assay, we tested all samples by an
additional confirmatory assay (nPCR) in a blinded fash-
ion. Comparison of real-time PCR and nPCR as a refer-
ence test in 52 clinical specimens resulted in an excellent
agreement. Conversely, the results of reference nPCR and
antigen ELISA disagreed. The clinical performance of anti-
gen ELISA and real-time PCR after additional testing by
nPCR are listed in Table 3.
Viral loads
To explain the substantial difference of the results by real-
time PCR and antigen ELISA, we compared the viral load
of PCR-positive ELISA-positive specimens with those of
PCR-positive but ELISA-negative specimens. This compar-
ison is based on the assumption that high Ct values are
representative of low viral load, whereas low Ct values are
representative for high viral load. The mean Ct values
obtained by real-time PCR for ELISA-positive and ELISA-
negative samples were 31.2 (range 26.7 to 34) and 27.7
(range 18.5 to 34), respectively. Statistical significance
between the mean Ct values of ELISA-positive and ELISA-
negative samples was tested by the Mann-Whitney U test
(p = 0.039). The actually higher Ct values of ELISA-posi-
tive samples indicate that NoV RNA was even present at
lower levels in these samples. On the basis of this finding,
the failure to detect virus antigen in some real-time PCR
positive samples cannot be explained by low virus titer in
the samples.
Discussion
It is generally assumed that ELISA antigen techniques are
less sensitive than PCR-based assays and therefore we
choose the latter as the routine diagnostic assay for detec-
tion of NoV RNA in patient specimens. To validate the
performance of our new real-time assay we collaborated
with another diagnostic laboratory performing nPCR
analysis for NoV detection. This approach ensures that
primer annealing temperatures are stringent enough and
that Tm analysis reliably distinguishes the specific PCR
products and possible PCR by-products. We consider
nPCR as a reliable test that can be used as a reference
method for the following reasons: (i) the efficiency of the
nPCR has been previously shown to work well in outbreak
investigations [22-24], and (ii) the nPCR primer set has
been proven recently in an international collaborative
study [25], adding further confidence to the specificity of
the reference test used.
All real-time PCR-positive results were confirmed by
nPCR. This congruence offers a firm background for the
clinical utility and performance of the new real-time
assay. Furthermore, compared to the nPCR protocol, the
routine work flow reduced hands on-time and the turna-
round time to the final result allowed same-day reporting
to the clinician.
Consistent with previous studies [26,27], we found anti-
gen ELISA to be significantly less sensitive than real-time
PCR (34.6% vs. 100%; P < 0.001%). We regard the
positive results by real-time PCR as reliable on the
strength of following reasons. First, the combined use of a
stringent hot start PCR and touch-down cycling condi-
tions reduces the formation of non-specific amplification
products and primer-dimers. Second, the characteristic Tm
of the target was determined by melting curve analysis to
prevent false-positive results. Third, and most important,
all results were corroborated by the reference nPCR. By
use of these compelling criteria, it can be considered that
false-positive results are unlikely.
Different sample volume analyzed could account for the
differing results. To proof this, we compared the viral load
of PCR-positive ELISA-positive specimens with those of
PCR-positive but ELISA-negative samples. The first cycle at
which the fluorescence passes from background levels to
clearly detectable is called the threshold cycle (Ct). This
value serves as a tool for calculating semiquantitatively
the amount of starting template in the clinical sample, i.e.
the higher the Ct, the lower the amount of starting tem-
plates. Surprisingly, the mean Ct values were significantly
higher in PCR-positive ELISA-positive samples, indicating
the presence of even lower levels of viral RNA. In this
regard, it is particularly relevant that in stool NoV antigens
are present in higher concentrations than intact virus par-
ticles [28] suggesting that stool antigen concentrations
could not have affected the performance of antigen ELISA.
Although, the Ct values depend greatly on the homology
of primer and target sequences, it is unlikely that the
results are biased by a special NoV genotype, since the
samples originate from different geographical regions in
Germany. Sequence determination of these strains was
not done. Alternatively, the failure to detect viral antigen
in some of the real-time PCR positive samples could be
due to the wide genetic diversity of NoV. Although anti-
Table 3: Comparison of real-time PCR and Elisa test performance 
to nPCR
Laboratory Test No. of specimens with test result/no. specimens 
with result by nPCR as reference (%)
Sensitivity Specificity
Elisa 9/26 (34.6) 17/26 (65.3)
Real-time PCR 26/26 (100) 26/26 (100)BMC Infectious Diseases 2004, 4 http://www.biomedcentral.com/1471-2334/4/15
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gen ELISA are broadly reactive, the monoclonal antibod-
ies used in the test may detect only antigenically similar or
the most closely related NoV strains.
Only 9 of 18 ELISA-positive results could be confirmed by
real-time PCR and nPCR, respectively, Factors that may
adversely affect the sensitivity of the amplification assays
include inefficient RNA extraction procedure, PCR inhibi-
tors in faecal samples, and RNA degradation before test-
ing. To rule out PCR inhibitors, we spiked all 9 ELISA-only
positive samples with a NoV low-run control, but no PCR
inhibitiors were detected.
Other reasons for the inability to detect NoV RNA could
be low level of intact viral particles, or sequence variation
(e.g., mismatches at critical positions in the primer bind-
ing site) in the viral RNA polymerase region. This is con-
sistent with previous reports of genomic diversity of NoV
strains even in the conserved region of open reading frame
1 (ORF1) coding for the viral RNA polymerase [29,30]. To
rule out that we have missed these strains due to genetic
variability, we have tested in addition all nine ELISA-only
positive samples with a PCR-protocol using the primer
pair JV12-JV13 targeting the RNA-dependent RNA
polymerase gene [25]. All 9 ELISA-only positive samples
were also negative by using this protocol. Thus, it is very
unlikely that the negative result by real-time PCR was
related to genetic variability.
On the other hand, false positive results of the antigen
ELISA cannot be excluded. Two of the nine ELISA-only-
positive samples had OD values that were in the equivocal
range of the assay, i.e. marginally above the cut-off level of
the test. These results were not resolved upon retesting.
Notably, three of the samples with the high OD values of
2.5, 3.3, and 3.6 in the antigen ELISA were negative by
real-time PCR.
Clearly the design of primer and probes capable for
detecting a broad range of NoV strains is an ongoing chal-
lenge given the genetic diversity of the NoV genus.
Recently, a real-time RT-PCR assay was established with
sequence-specific probes for detection of NoV [31]. The
use of SYBR Green offers the advantage of real-time detec-
tion even in the case of template sequence variation,
which may abolish detection using hybridization probes.
There are two limitations to this study: (i) no internal con-
trol is added to the specimens prior to nucleic acid extrac-
tion as provided in part by commercially developed
assays, and (ii) since our assay is based on SYBR Green,
the assay cannot distinguish between NoV of GI and GII.
In conclusion, we describe a real-time PCR assay which
detects the presence of NoV RNA in stool samples. The
new assay provides accurate diagnostic results in less time
than currently employed conventional PCR-assays. The
automated sample preparation offers high throughput
without cross-contamination of specimens during
processing as well as standardization of operation steps.
There is a keen interest in rapid and reliable assay in clin-
ical situations to contain the spread of the virus in hospi-
tals or other settings such as geriatric care facilities.
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